{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T02:58:05Z","timestamp":1717383485037},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMC"],"published-print":{"date-parts":[[2009,6,1]]},"DOI":"10.2174\/092986709788453122","type":"journal-article","created":{"date-parts":[[2009,5,30]],"date-time":"2009-05-30T13:43:18Z","timestamp":1243690998000},"page":"2212-2234","source":"Crossref","is-referenced-by-count":10,"title":["Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity"],"prefix":"10.2174","volume":"16","author":[{"given":"Tadeusz","family":"Robak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/69295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T08:44:32Z","timestamp":1448009072000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=0929-8673&volume=16&issue=18&spage=2212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,1]]},"references-count":0,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/092986709788453122","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6,1]]}}}